Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.950
-0.040 (-2.01%)
At close: Apr 7, 2026, 4:00 PM EDT
2.010
+0.060 (3.09%)
After-hours: Apr 7, 2026, 7:48 PM EDT

Enveric Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4244430
Market Cap Growth
11.55%-40.59%2.43%-17.61%-85.73%-40.61%
Enterprise Value
-12.173.651.27-12.5213
Last Close Price
1.953.6364.56234.00374.408370.00
PE Ratio
--0.10-0.28-0.16-0.16-0.45
PB Ratio
0.50-0.02-0.031.820.291.36
P/TBV Ratio
-0.01-0.01-0.031.440.210.99
P/FCF Ratio
--0.27-0.47-0.25-0.24-2.60
P/OCF Ratio
--0.27-0.47-0.25-0.25-2.64
EV/EBITDA Ratio
--0.25-0.39-0.080.46-0.20
EV/EBIT Ratio
--0.25-0.38-0.080.46-0.20
EV/FCF Ratio
--0.27-0.47-0.090.71-1.12
Debt / Equity Ratio
-00000.00
Debt / EBITDA Ratio
----0.000.00
Debt / FCF Ratio
----0.00-0.01
Net Debt / Equity Ratio
----1.17-1.20-0.77
Net Debt / EBITDA Ratio
---0.140.660.27
Net Debt / FCF Ratio
---0.161.001.48
Quick Ratio
-000.984.446.34
Current Ratio
5.385.381.841.534.616.48
Return on Equity (ROE)
7.94%7.94%18.39%-197.47%-97.57%-380.82%
Return on Assets (ROA)
-214.57%-214.57%-260.71%-137.69%-127.32%-364.01%
Return on Invested Capital (ROIC)
-287.54%-287.54%-1247.24%5276.20%-835.99%-1216.07%
Return on Capital Employed (ROCE)
-304.12%-304.12%-542.79%-187.84%-138.67%-471.75%
Earnings Yield
-329.60%-998.35%-353.90%-622.06%-625.07%-222.99%
FCF Yield
-221.20%-375.70%-211.81%-395.92%-410.20%-38.45%
Buyback Yield / Dilution
-698.70%-698.70%-249.41%-49.30%-206.14%17.29%
Total Shareholder Return
-698.70%-698.70%-249.41%-49.30%-206.14%17.29%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q